Contraceptives Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Contraceptives Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Contraceptives Market

The Contraceptives Treatment market size was valued at USD 22.49 billion in 2023, and the market is now projected to grow to USD 30.15 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period of 2024-2032.

A negative effect on the contraceptives market growth amid the estimate period was witnesses by the havoc of COVID-19 pandemic. This is often majorly due to the disturbed access for contraception among the populace. Major disturbances to wellbeing administrations owing to continuous lockdowns, amid the COVID-19 widespread may leave 47 million ladies in center and low-income nations incapable to utilize novel birth control medications, leading to 7 million unintended pregnancies within the coming months. Besides, a decay within the manufacturing and supply amounts of birth control pills over the globe is another critical calculate coming about within the drop of the market development rate.

Low-dose COCs containing 20-35 micrograms of ethinylestradiol combined with progestogen have generally supplanted the more seasoned COCs comprising 50 micrograms estrogen. Low-dose COCs are favored since of the lower hazard of venous thromboembolism. The rising number of clinical inquiries about relating to birth control strategies for way better proficiency will emphatically recommend a positive development direction over the analysis period.

The persistently developing rate of the worldwide populace, particularly within the developing economies could be a rising concern around the world, hence advancing the require for government activities is driving mindfulness campaigns to dispose of or minimize the hazard of undesirable pregnancies, chance related with premature birth, and sexual disorders risk. The developing rate of undesirable pregnancies around the world may be a major concern among the population. As per the Centers for Illness Control and Prevention (CDC), 45% of the 6.1 million yearly pregnancies within the U.S. are undesirable. Thus, the expanding rate of unintended pregnancies will goad the market development over the estimate period.

Comprehensive Analysis of Contraceptives Treatment Market

Contraceptives drug and contraceptive devices are the two types of bifurcation analyzed on the basis of product type. The product drug is termed to be the most utilized product of the contraceptive market. Male and female are the two subordinated of the contraceptive market. A spike in the product utilization is being observed by the male segment. Retail pharmacies, hospital pharmacies and the online channels are the 3 coordinates of the distribution channel of the contraceptives market pool.

The contraceptives market share in North America is valued at USD 9.71 billion in the forecasted period. The region's dominance on the market is inferable to the expanding rate of unintended pregnancies over the region. Additionally, the developing number of high schooler pregnancies over the U.S. will encourage increase territorial development. For occurrence, as per the Centers for Disease Control and Anticipation (CDC), in 2017, the pregnancy rate in ladies matured 15–19 a long time expanded to 18.8% per 1,000 ladies. Besides, the nearness of major players working within the region will advance boost item deals.

The structure of this market is divided in nature owing to the plenty of items accessible for utilize. Besides, the expanding number of producers and an exceptional dissemination organize of major companies within the created and rising economies will assist expand market extension. Currently, the three companies Pfizer Inc. (U.S.), Bayer (Germany), and Merck & Co. Inc. (U.S.), are driving the market, bookkeeping for an overwhelming share in 2019. The other key players in this market incorporate Cooper Surgical Inc. (U.S.), Actavis, Inc., Teva Pharmaceutical Industries Limited (Israel), Cooper Surgical, Inc. (U.S.), Church & Dwight, Co., Inc. (U.S.), The Female Health Company (U.S.), Church & Dwight, Co., Inc. (U.S.), Medisafe Distribution Inc. (U.S.) and others.

In between the month of June 2021, The Emme, a health tech company that propelled a birth control following keen case and app has presently extended its offerings into medicine conveyance and telemedicine. The new extension, known as EmmeRx, implies patients in 16 states will be able to urge contraception endorsed and conveyed.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2016-2027

Base Year 2019

Forecast Period 2020-2027

Historical Period 2016-2018

UnitValue (USD billion)

By ProductContraceptive Drugs

Oral

Injectable

Patches

Contraceptive Devices

Male Contraceptive Devices

Female Contraceptive Devices

By GenderMale

Female

By Distribution ChannelHospital Pharmacy

Retail Pharmacy

Clinics

Online Channel

Public Channel & NGO

Others

By GeographyNorth America

By Product

By Gender

By Distribution Channel

By Country

Europe

By Product

By Gender

By Distribution Channel

By Country

Asia Pacific

By Product

By Gender

By Distribution Channel

By Country

Latin America

By Product

By Gender

By Distribution Channel

By Country

Middle East & Africa

By Product

By Gender

By Distribution Channel

By Country

Please Note: It will take 5-6 business days to complete the report upon order confirmation.